SNT 2.94% 3.3¢ syntara limited

I remain a holder, but not a buyer. I should probably sell but...

  1. 594 Posts.
    lightbulb Created with Sketch. 281
    I remain a holder, but not a buyer. I should probably sell but as I am already down 80% or so, emotionally it is hard to let go.

    I don't expect any news for some time.

    I expect FDA approval for adults following completion of the trial, but that is still some time away. The outcome of EU pead trial is more questionable.

    The biggest problem is simply that it is not selling, or providing revenues of any substance. The company is just too big and the revenue too small. The latest investor presentation did not reassure me. The BIG plan seemed to be selling two experimental drugs that have never been tested in humans before.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.